Form 4: Incyte EVP & Chief Medical Officer Steven H. Stein Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Steven H. Stein, EVP & Chief Medical Officer of Incyte Corp, reports a transaction involving common stock due to tax withholding obligations.
Summary
- On July 2, 2024, Steven H. Stein, EVP & Chief Medical Officer of Incyte Corp, reported a transaction involving Incyte's common stock.
- 8,316 shares were disposed of at a price of $59.02 per share to satisfy tax withholding obligations.
- Following the transaction, Stein beneficially owns 89,279 shares of Incyte common stock, which includes 76,940 shares issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects a routine transaction for tax purposes and doesn't indicate any strategic shift or concern.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/02/2024 | Date of transaction: disposal of shares for tax withholding. |
| 07/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.